Jon H. Meyerle, MD

Bullous Systemic Lupus Erythematosus Successfully Treated With Rituximab

Author:: Christopher D. Lowe, MD; Catherine A. Brahe, MD; Brian Green, DO; Thomas K. Lam, MD; Jon H. Meyerle, MD

Bullous systemic lupus erythematosus can present with a waxing and waning course punctuated by flares. This case illustrates the role of rituximab...

Author:: Hannah B. Harris, MD; Benjamin J. Kurth, MD; Thomas K. Lam, MD; Jon H. Meyerle, MD

It is important for physicians to recognize the clinical appearance of cutaneous adverse reactions to heparin, including bullous hemorrhagic...

Amputees have an increased risk for skin disease occurring at residual limb sites. Although prosthetists and primary care physicians often...

Author:: Kenneth J. Helmandollar, MD; Kara R. Hoverson, MD; Jon H. Meyerle, MD

We report the case of an 8-year-old boy who was taking amantadine off label for multiple childhood neurobehavioral disorders and subsequently...

Early detection of skin cancer is essential to reducing morbidity and mortality from both melanoma and nonmelanoma skin cancers. Total-body skin...

This article outlines the unique resources available in the US Military to investigate epidemiologic trends, disease pathology, and clinical...